Table 2. Main characteristics of patients infected with GT2 and GT3 (Mean).
mean | SD | n | mean | SD | n | ||
Age (years) | 45.4 | 12.1 | 391 | 38.3 | 9.6 | 1956 | <0.0001 |
Duration of infection (years) | 13.9 | 10.2 | 332 | 10.1 | 7.8 | 1743 | <0.0001 |
BMI | 25.9 | 4.7 | 391 | 24.9 | 4.1 | 1956 | <0.0001 |
APRI score | 0.8 | 1.1 | 346 | 1.0 | 1.3 | 1780 | 0.005 |
Thrombocytes/nl | 224 | 75 | 376 | 220 | 72 | 1885 | 0.400 |
Prothrombine time (%) | 97.5 | 12.0 | 245 | 96.9 | 14.2 | 1155 | 0.124 |
γ-GT (U/L) | 68 | 109 | 370 | 79 | 104 | 1872 | 0.061 |
Cholesterol (mg/dl) | 194 | 40 | 220 | 166 | 53 | 1037 | <0.0001 |
LDL cholesterol (mg/dl) | 116 | 34 | 120 | 95 | 36 | 532 | <0.0001 |
Triglycerides (mg/dl) | 130 | 92 | 210 | 119 | 77 | 945 | 0.073 |
Ferritin (µg/L) | 193 | 410 | 150 | 165 | 173 | 657 | 0.409 |
Duration of therapy (weeks) | 24.8 | 8.8 | 391 | 24.4 | 10.0 | 1950 | 0.492 |
RBV starting dose (mg/kg/day) | 12.6 | 3.0 | 390 | 12.6 | 3.4 | 1950 | 0.767 |